A Study to Investigate the Effect of Probiotics (L. Reuteri ATCC PTA 5289 and L. Reuteri DSM 17938) on Symptoms of Viral Upper Respiratory Tract Infections in Children

NARecruitingINTERVENTIONAL

Enrollment

142

Participants

Timeline

Start Date

December 21, 2023

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2025

Conditions

Virus Diseases in Children

Interventions

DIETARY_SUPPLEMENT

BioGaia Pharax (L. reuteri PTA 5289 and DSM 17938)

BioGaia Pharax drops (with PTA5289 and DSM 17938) with vitamin D3 will be manufactured and delivered by BioGaia AB as oil suspension.

OTHER

Placebo

Placebo product contains vitamin D3 and is identical to the active product but lacks L. reuteri.

Trial Locations (1)

RECRUITING

Szent Miklós Szolgálat Kft., Szigetszentmiklós

All Listed Sponsors

lead

Milosevits Gergely

OTHER